LONG TERM FOLLOW UP OF 5 PATIENTS TREATED WITH MESENCHYMAL STROMAL CELL IMMUNOMODULATORY THERAPY FOR LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Tan, D. [3 ]
Carnley, B. [1 ,3 ]
Sturm, M. [4 ]
Cirillo, M. [1 ,2 ]
机构：
[1] Royal Perth Hosp, Haematol, Perth, WA, Australia
[2] Univ Western Australia, Pathol, Fac Hlth & Med Sci, Perth, WA, Australia
[3] Royal Perth Hosp, Cell & Tissue Therapies WA, Perth, WA, Australia
[4] Isopogen Pty Ltd, Perth, WA, Australia
来源：
CYTOTHERAPY | 2024年 / 26卷 / 06期
关键词：
Myelodysplastic Syndrome; Immunotherapy;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
112
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] PHASE 1 SAFETY OUTCOMES OF MESENCHYMAL STROMAL STEM CELL THERAPY IN PATEINTS WITH LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROME
    Cirillo, M.
    Carnley, B.
    Tan, P.
    Tan, D.
    Sturm, M.
    [J]. CYTOTHERAPY, 2018, 20 (05) : S31 - S31
  • [2] OUTCOMES OF CONTINUED AZACITIDINE TREATMENT FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME IN IPSS LOW AND INTERMEDIATE-1
    Moon, J. H.
    Sohn, S. K.
    Cho, Y. Y.
    Kim, Y. K.
    Kim, H. J.
    Kim, M. K.
    Do, Y. R.
    Song, M. K.
    Lee, W. K.
    Lee, S. M.
    Kim, H.
    Won, J. H.
    Yeon, J. Deok
    [J]. HAEMATOLOGICA, 2012, 97 : 141 - 141
  • [3] Cytogenetic Evolution in Patients with IPSS Low and Intermediate-1 Risk. Study from the Spanish Group of Myelodysplastic Syndrome
    Marcel Merchan, Brayan
    Ortega, Margarita
    Jose Llamas-Poyato, Mara
    Cortes, Montserrat
    Arnan, Montserrat
    Cervero, Carlos
    Montoro, Julia
    Gimenez, Teresa
    Lopez, Mara
    Arenillas, Leonor
    Valcarcel, David
    [J]. BLOOD, 2014, 124 (21)
  • [4] ACQUISITION OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH IPSS LOW AND INTERMEDIATE-1 RISK. STUDY FROM THE SPANISH GROUP OF MYELODYSPLASTIC SYNDROME
    Merchan, B.
    Ortega, M.
    Llamas-Poyato, M. J.
    Cortes, M.
    Arnan, M.
    Cervero, C.
    Montoro, J.
    Gimenez, T.
    Lopez, M.
    Arenillas, L.
    Valcarcel, D.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S136 - S136
  • [5] The in vitro effect of SB-497115 (Eltrombopag) on megakaryopoiesis of patients with low/intermediate-1 IPSS myelodysplastic syndrome
    Papadaki, H.
    Mavroudi, I.
    Psyllaki, M.
    Pyrovolaki, K.
    Papadaki, V.
    Kalpadakis, C.
    Mastrodimou, S.
    Kaparou, M.
    Kanellou, P.
    Gvazava, G.
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S47 - S48
  • [6] Improved survival rates with continued treatment with hypomethylating agents in patients with myelodysplastic syndrome in IPSS low and intermediate-1
    Moon, J.
    Sohn, S. K.
    Kim, Y. K.
    Kim, H. J.
    Lim, S. N.
    Kim, M. K.
    Do, Y. R.
    Song, M. K.
    Lee, W. S.
    Lee, S. M.
    Kim, H.
    Won, J. H.
    Jo, D. Y.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S165 - S166
  • [7] CLINICAL BENEFIT OF LENALIDOMIDE TREATMENT FOR LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROME WITH DEL(5Q) BEFORE TRANSFUSION DEPENDENCE
    Oliva, E.
    Lauseker, M.
    Spiriti, M. A. Aloe
    Poloni, A.
    Cortelezzi, A.
    Palumbo, G.
    Balleari, E.
    Sanpaolo, G.
    Volpe, A.
    Ricco, A.
    Ronco, F.
    Alati, C.
    Santacaterina, I.
    Kuendgen, A.
    Germing, U.
    Latagliata, R.
    [J]. HAEMATOLOGICA, 2014, 99 : 517 - 517
  • [8] Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload
    Ivars, David
    Collado, Rosa
    Alguero, Carmen
    Carmen Tormos, M.
    Diaz, Laura
    Luis Garcia-Ghnenez, Jose
    Arrizabalaga, Beatriz
    Orero, Mayte
    Perez, Pedro
    Sanchez, Magdalena
    Angeles Ruiz, M.
    Yaguee, Nuria
    Sancho-Tello, Reyes
    Regadera, Ana
    Tormo, Mar
    Egea, Mercedes
    Vidal, Elena
    Enrique O'Connor, J.
    Saez, Guillermo T.
    Carbonell, Felix
    [J]. BLOOD, 2012, 120 (21)
  • [9] 5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program
    Musto, Luca Maurillo
    Spagnoli, Alessandra
    Gozzini, Antonella
    Rivellini, Flavia
    Tatarelli, Caterina
    Lunghi, Monia
    Fili, Carla
    Orciuolo, Enrico
    Ciuffreda, Lucia
    Vigna, Ernesto
    Della Cioppa, Paola
    Candoni, Anna
    Ferrero, Dario
    Palmieri, Salvatore
    Palumbo, Giuseppe
    Di Renzo, Nicola
    Oliva, Esther
    Sanpaolo, Grazia
    Pastore, Domenico
    Tonso, Anna
    Santagostino, Alberto
    Rocco, Stefano
    Villani, Oreste
    D'Auria, Fiorella
    D'Arco, Alfonso Maria
    Gaidano, Gianluca
    Galimberti, Sara
    Russo, Domenico
    Venditti, Adriano
    Aloe-Spiriti, Maria Antonietta
    Leone, Giuseppe
    Santini, Valeria
    [J]. BLOOD, 2008, 112 (11) : 926 - 927
  • [10] 5-AZACYTIDINE FOR THE TREATMENT OF LOW/INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 63 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
    Musto, P.
    Maurillo, L.
    Spagnoli, A.
    Gozzini, A.
    Rivellini, F.
    Tatarelli, C.
    Lunghi, M.
    Fili, C.
    Orciuolo, E.
    Ciuffreda, L.
    Vigna, E.
    Della Cioppa, P.
    Ferrero, D.
    Palmieri, S.
    Palumbo, G.
    Di Renzo, N.
    Oliva, E.
    Sanpaolo, G.
    Pastore, D.
    Tonso, A.
    Santagostino, A.
    Villani, O.
    D'Auria, F.
    D'Arco, A.
    Gaidano, G.
    Galimberti, S.
    Russo, D.
    Venditti, A.
    Aloe-Spiriti, M. A.
    Leone, G.
    Santini, V.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 368 - 368
12345